icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Time from diagnosis to treatment in vulnerable populations versus general population: Do we test-and-treat our HCV patients in the same way?
 
 
  AASLD 2020 Nov 11-16 virtual
Reported by Jules Levin

vun

Khalili M1, Carrat F2, Barrett L3, Mangia A4, Lardo S5, Canete N6, Ramji A7, Teti E8, Acosta-Lopez S9, Wong A10, Rodriguez-Tajes S11, Fraser C12, Jimenez Mutiloa E13, Castro S14, Young M15, Macedo G16, Milella M17, Buti M18, Guerra Veloz MF19, Martins Figueiredo L20, Princic E21, Bascia A22, Brixko C23, de Ledinghen V24, Valencia J25, Conway B26, Fenech M27, Gutierrez M-L28, Fagiuoli S29, Giuliani R30, Campanale31, Mertens M32, Hernandez-Lopez C32, Ntalla I33, Vanstraelen K32, Calvaruso V34
1TARGET cohort, University of California San Francisco, CA, USA; 2ANRS Hepather cohort, Sorbonne Universite, INSERM, IPLESP, APHP, France; 3Infectious Diseases, NSHA/Dalhousie University, Halifax, NS, Canada; 4Irccs-Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy; 5San Raffaele Pisana IRCCS, Rome, Italy; 6Liver Section, Gastroenterology Department, Hospital del Mar, Parc de Salut Mar, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; 7University of British Columbia, BC, Canada; 8Infectious Diseases Clinic, Tor Vergata University, Rome, Italy; 9Liver Unit, Complejo Hospitalario Nuestra Senora de Candelaria, Tenerife, Spain; 10Department of Medicine, University of Saskatchewan, Regina, SK, Canada; 11Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Ciberehd, Spain; 12Cool Aid Community Health Centre, Victoria, BC, Canada; 13Hospital Universitario Insular de Gran Canaria, Spain; 14Galicia South Health Research Institute, Vigo, Spain; 15Kombi Clinic & Medeco Inala, Brisbane, QLD, Australia; 16Department of Gastroenterology and Hepatology, Centro Hospitalar Sao Joao,Porto; Faculty of Medicine, Porto, Portugal; 17Clinic of Infectious Diseases, University of Bari, Italy; 18Liver Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Barcelona, Spain; 19Virgen Macarena University Hospital, Seville, Spain; 20Hospital Prof Dr Fernando Fonseca, Amadora, Portugal; 21Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Italy; 22Infectious Disease Department Polyclinic "Cittadella della Salute" ASL Lecce and Infectious Diseases Consultant of San Borgo San Nicola detention center, Lecce, Italy; 23CHR Citadelle, Department Gatroenterol & Digest Oncol, Liege, Belgium; 24Centre Hospitalier Universitaire Bordeaux, France; 25Harm reduction unit, Madrid, Spain; 26Infectious Diseases, Vancouver Infectious Diseases Centre, Vancouver, BC, Canada; 27Queensland Injectors Health Network Ltd., Better Access Medical Clinic, Brisbane, QLD, Australia; 28Hospital Universitario Fundacion Alcorcon, Spain; 29Asst Papa Giovanni XXIII, Italy - Lombardia HCV Network; 30Penitentiary Infectious Disease Service San Paolo Hospital University of Milano, Italy; 31Local health department BAT, ASL BAT and Infectious Diseases Consultant of Detention Center, Trani, Italy; 32Medical Affairs, Gilead Sciences Europe Ltd. UK; 33Data Science & Biometrics, Epidemiology, Gilead Sciences Europe Ltd. UK; 34Gastroenterology and Hepatology Unit, Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities, PROMISE; University of Palermo, Italy